García C E, Kilcoyne C M, Cardillo C, Cannon R O, Quyyumi A A, Panza J A
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. 20892, USA.
Hypertension. 1995 Dec;26(6 Pt 1):863-8. doi: 10.1161/01.hyp.26.6.863.
Patients with essential hypertension have abnormal endothelium-dependent vasodilation related to decreased nitric oxide activity. The specific mechanism responsible for this abnormality is unknown. Recent studies in hypertensive animals have suggested an augmented destruction of nitric oxide by superoxide anions. Therefore, in the present study we aimed to investigate whether this mechanism is responsible for the abnormal vasodilator function of hypertensive patients. To this end, we studied the vascular responses to acetylcholine (an endothelium-dependent vasodilator) and sodium nitroprusside (a direct smooth muscle dilator) before and after combined administration of copper-zinc superoxide dismutase (a scavenger of superoxide anions with poor intracellular penetrance; 6000 U/min) in 20 healthy control subjects (11 men and 9 women; aged 50 +/- 6 years) and 20 hypertensive patients (13 men and 7 women; aged 51 +/- 9 years). Drugs were infused into the brachial artery, and the response of the forearm vasculature was measured by plethysmography. The vasodilator response to acetylcholine was significantly blunted in hypertensive patients compared with control subjects (maximal flow: 8.2 +/- 4 versus 12.7 +/- 3 mL/min per 100 mL; P < .02); however, no difference was observed in the response to sodium nitroprusside (8.1 +/- 4 versus 9.5 +/- 3 mL/min per 100 mL). In healthy control subjects superoxide dismutase infusion did not modify the vasodilator response to acetylcholine (maximal flow: 12.7 +/- 3 before versus 12.1 +/- 3 after superoxide dismutase). Similarly, in hypertensive patients superoxide dismutase infusion did not alter the response to acetylcholine (maximal flow: 8.2 +/- 4 versus 7.7 +/- 4).(ABSTRACT TRUNCATED AT 250 WORDS)
原发性高血压患者存在与一氧化氮活性降低相关的内皮依赖性血管舒张异常。导致这种异常的具体机制尚不清楚。最近对高血压动物的研究表明,超氧阴离子会增强对一氧化氮的破坏。因此,在本研究中,我们旨在调查该机制是否导致高血压患者血管舒张功能异常。为此,我们研究了20名健康对照者(11名男性和9名女性;年龄50±6岁)和20名高血压患者(13名男性和7名女性;年龄51±9岁)在联合给予铜锌超氧化物歧化酶(一种细胞内穿透性较差的超氧阴离子清除剂;6000 U/分钟)前后,对乙酰胆碱(一种内皮依赖性血管舒张剂)和硝普钠(一种直接作用于平滑肌的血管舒张剂)的血管反应。将药物注入肱动脉,通过体积描记法测量前臂血管系统的反应。与对照者相比,高血压患者对乙酰胆碱的血管舒张反应明显减弱(最大血流量:每100 mL 8.2±4与12.7±3 mL/分钟;P<.02);然而,对硝普钠的反应未观察到差异(每100 mL 8.1±4与9.5±3 mL/分钟)。在健康对照者中,注入超氧化物歧化酶并未改变对乙酰胆碱的血管舒张反应(最大血流量:注入超氧化物歧化酶前为12.7±3,注入后为12.1±3)。同样,在高血压患者中,注入超氧化物歧化酶也未改变对乙酰胆碱的反应(最大血流量:8.2±4与7.7±4)。(摘要截断于250字)